These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 15308391
21. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes. Rave K, Heise T, Pfützner A, Boss AH. Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744 [No Abstract] [Full Text] [Related]
22. [Treating hyperglycemia of type 2 diabetes with intravenous insulin infusion]. Vanamo R. Duodecim; 1997 Sep; 113(5):423-7. PubMed ID: 11370085 [No Abstract] [Full Text] [Related]
28. Improving glycemic control in medical inpatients: a pilot study. Trujillo JM, Barsky EE, Greenwood BC, Wahlstrom SA, Shaykevich S, Pendergrass ML, Schnipper JL. J Hosp Med; 2008 Jan; 3(1):55-63. PubMed ID: 18257047 [Abstract] [Full Text] [Related]
29. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391 [Abstract] [Full Text] [Related]
30. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Langer O, Yogev Y, Xenakis EM, Rosenn B. Am J Obstet Gynecol; 2005 Jan; 192(1):134-9. PubMed ID: 15672015 [Abstract] [Full Text] [Related]
34. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)]. Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T. Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091 [Abstract] [Full Text] [Related]
36. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study. Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T. Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593 [Abstract] [Full Text] [Related]
37. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT. Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002 [Abstract] [Full Text] [Related]
38. New technologies and therapies in the management of diabetes. Triplitt CL. Am J Manag Care; 2007 Apr; 13 Suppl 2():S47-54. PubMed ID: 17417933 [Abstract] [Full Text] [Related]
39. Newly identified hyperglycemia among hospitalized patients. Graber AL, McDonald T. South Med J; 2000 Nov; 93(11):1070-2. PubMed ID: 11095554 [Abstract] [Full Text] [Related]
40. [Oral drugs for diabetes--update of current use and availability]. Niskanen L. Duodecim; 2004 Nov; 120(8):983-90. PubMed ID: 15185512 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]